Table 4: Here
Six patients in placebo group and 7 patients in silymarin group
experienced gastrointestinal symptoms (e.g., epigastric pain, nausea and
vomiting). Three patients in silymarin group and 2 patients in placebo
group discontinued the trial due to side effects. Overall, the side
effects were tolerable and were managed with advising patients to
receive the study drug after meal.